ASHS – Rhode Island Proton Beam Radiation Therapy, a subsidiary of American Shared Hospital Services (AMS), has received a certificate of need (CON) for acquiring technology needed to build and operate a freestanding proton beam radiation treatment (PBRT) system in Johnston.
This development follows the Health Service Council’s unanimous recommendation and subsequent approval by the Rhode Island Department of Health director.
Go deeper with GlobalData
AMS radiation oncology senior vice-president Greg Mercurio said: “The achievement of this CON is one of the three unique and local business opportunities we focused on and have successfully achieved and represents a potential growth driver for AMS locally and nationally.
“Currently, there are only two Proton Beam Radiation Therapy Systems in operation in the Northeast, and this facility, being conveniently located between the New York City and Boston Proton facilities, would create greater access to this cutting-edge, cancer-fighting technology in the Northeast.”
The CON enables the company, a provider of healthcare technology solutions, to provide radiation therapy technology to the Rhode Island cancer care community.
This initiative is expected to enhance the coordinated cancer care available to patients in the region.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataAMS executive chairman and CEO Ray Stachowiak said: “This facility would be our latest addition to the three Rhode Island photon radiation therapy facilities, in which AMS is the 60% majority owner in conjunction with the second and third largest health systems in RI.
“To assist with these initiatives, the company has recently added executives to its senior management team with many years of expertise and success in the development, acquisition, and operation of free-standing radiation therapy facilities, as well as partnering with health systems to grow their oncology service lines.”
The new facility is expected to be operational and treat its first patients within 36 to 39 months.
